335 related articles for article (PubMed ID: 24312590)
41. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.
Rodrigues TM; Castro Caldas A; Ferreira JJ
Parkinsonism Relat Disord; 2016 Jun; 27():25-34. PubMed ID: 27010071
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy.
Jasinski DR; Kovacević-Ristanović R
Clin Neuropharmacol; 2000; 23(3):149-56. PubMed ID: 10895398
[TBL] [Abstract][Full Text] [Related]
43. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
Becker PM; Schwartz JR; Feldman NT; Hughes RJ
Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.
Rammohan KW; Rosenberg JH; Lynn DJ; Blumenfeld AM; Pollak CP; Nagaraja HN
J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):179-83. PubMed ID: 11796766
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.
Subedi R; Singh R; Thakur RK; K C B; Jha D; Ray BK
Sleep Med; 2020 Nov; 75():510-521. PubMed ID: 33032062
[TBL] [Abstract][Full Text] [Related]
46. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
47. Modafinil: a second look. Confirmed efficacy in narcolepsy.
Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
[TBL] [Abstract][Full Text] [Related]
48. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
Zifko UA; Rupp M; Schwarz S; Zipko HT; Maida EM
J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
[TBL] [Abstract][Full Text] [Related]
49. Modafinil for Parkinson's disease fatigue.
Tyne HL; Taylor J; Baker GA; Steiger MJ
J Neurol; 2010 Mar; 257(3):452-6. PubMed ID: 19842011
[TBL] [Abstract][Full Text] [Related]
50. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Talbot K; Stradling J; Crosby J; Hilton-Jones D
Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
[TBL] [Abstract][Full Text] [Related]
51. Double-Blind, Placebo-Controlled, Crossover Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia.
Krystal AD; Preud'homme XA
Sleep; 2017 Jan; 40(1):. PubMed ID: 28364461
[TBL] [Abstract][Full Text] [Related]
52. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ
Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766
[TBL] [Abstract][Full Text] [Related]
53. Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use.
Prado E; Paholpak P; Ngo M; Porter V; Apostolova LG; Marrocos R; Ringman JM
Am J Alzheimers Dis Other Demen; 2012 Nov; 27(7):468-73. PubMed ID: 22892657
[TBL] [Abstract][Full Text] [Related]
54. Modafinil: new indications for wake promotion.
Schwartz JR
Expert Opin Pharmacother; 2005 Jan; 6(1):115-29. PubMed ID: 15709889
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of modafinil in patients with idiopathic hypersomnia without long sleep time: a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study.
Inoue Y; Tabata T; Tsukimori N
Sleep Med; 2021 Apr; 80():315-321. PubMed ID: 33631500
[TBL] [Abstract][Full Text] [Related]
56. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Moore DH; Barnes PR; Miller RG
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003218. PubMed ID: 16855999
[TBL] [Abstract][Full Text] [Related]
57. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
Inoue Y; Miki M; Tabata T
Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
[TBL] [Abstract][Full Text] [Related]
58. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
[TBL] [Abstract][Full Text] [Related]
59. Armodafinil for excessive daytime sleepiness.
Nishino S; Okuro M
Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
[TBL] [Abstract][Full Text] [Related]
60. Update on Persistent Excessive Daytime Sleepiness in OSA.
Javaheri S; Javaheri S
Chest; 2020 Aug; 158(2):776-786. PubMed ID: 32147246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
